ORTH ANDREW C.
SEC CIK 1860010 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | Chief Commercial Off | 12.6K | — | $1.61M | 2 | 2023-06-09 | 2023-06-09 |
Most active insiders at KRYS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Krishnan Suma | Pres, R, D, Dir, 10% | — | $34.27M |
| 2 | Krishnan Krish S | Pres, CEO, Dir, 10% | — | $34.27M |
| 3 | JANNEY DANIEL | Dir | — | $19.40M |
| 4 | ROSSI DINO A | Dir | — | $13.18M |
| 5 | ROMANO KATHRYN | CAO | — | $3.60M |
| 6 | Thomas John Charles | EVP, GC | — | $541.2K |
ORTH ANDREW C. made no open-market trades at KRYS in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-09 | 2023-06-09 | KRYS | Krystal Biotech, Inc. | ORTH ANDREW C. | Chief Commercial Off | M - OptEx | $63.55 | +12.5K | 12.6K | +12,500% | +$794.4K |
| DM | 2023-06-09 | 2023-06-09 | KRYS | Krystal Biotech, Inc. | ORTH ANDREW C. | Chief Commercial Off | S - Sale+OE | $128.61 | -12.5K | 7,339 | -63% | -$1.61M |
Purchase Sale Sale after option exercise All abbreviations